Skip to main content
. 2019 Mar 30;11(4):458. doi: 10.3390/cancers11040458

Figure 5.

Figure 5

ctRNA analysis of KRAS-mutated metastatic cancer patients (4). (A) Concentration of KRAS-mutated ctRNA (copies/mL); (B) KRAS-mutated ctRNA allele frequency (%).